The Art of Value Investing
  • Home
  • TheArtofValueInvesting.com
  • #FAQ
  • Business Related Article
  • Investing
    • Investing Lessons [Advanced]
    • Investing Lessons [Beginners]
    • My Stocks Updates
    • Stock Analysis [Advanced]
    • Stocks Analysis [Simple]
  • My Take on World Events
  • Options Selling
  • Summary of Courses and Books
  • Top Articles
  • Uncategorized
Select Page
Keryx Biopharmaceuticals: My Key Takeaways From Q4 2015 Results

Keryx Biopharmaceuticals: My Key Takeaways From Q4 2015 Results

by Chris Lee | Feb 28, 2016 | Investing, Investing Lessons [Advanced], My Stocks Updates

With the current market capitalization of $380.27 million, Keryx (NASDAQ: KERX) might not be your cheapest company to buy in terms of having a stake in their growth story. With growth story like this, there are risks involved. Current earning is still negative...
Next Entries »